Cited by 80RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryBarrier Structure and Function Studies

Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain

Open access
Mastorakos, Panagiotis, Zhang, Clark, Berry, Sneha, Oh, Yumin, Lee, Seulki, Eberhart, Charles G., Woodworth, Graeme F., Suk, Jung Soo +1 more·2015·Advanced Healthcare Materials

Abstract

Gene delivery to the central nervous system (CNS) has potential as a means for treating numerous debilitating neurological diseases. Nonviral gene vector platforms are tailorable and can overcome key limitations intrinsic to virus‐mediated delivery; however, lack of clinical efficacy with nonviral systems to date may be attributed to limited gene vector dispersion and transfection in vivo. It is shown that the brain extracellular matrix (ECM) strongly limits penetration of polymer‐based gene vector nanoparticles (NP) through the brain parenchyma, even when they are very small (<60 nm) and coated with a polyethylene glycol (PEG) corona of typical density. Following convection enhanced delivery (CED), conventional gene vectors are confined to the injection site, presumably by adhesive interactions with the brain ECM and do not provide gene expression beyond the point of administration. In contrast, it is found that incorporating highly PEGylated polymers allows the production of compacted (≈43 nm) and colloidally stable DNA NP that avoid adhesive trapping within the brain parenchyma. When administered by CED into the rat striatum, highly PEGylated DNA NP distribute throughout and provide broad transgene expression without vector‐induced toxicity. The use of these brain‐penetrating gene vectors, in conjunction with CED, offers an avenue to improve gene therapy for CNS diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/adhm.201400800

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PEGylated polymer nanoparticles similar in size and surface chemistry to LNPs were previously able to transfect DNA into brain tissue after an intracerebral injection, suggesting that LNPs will be able to transfect brain tissue after intracerebral injection.

    “Notably, PEGylated polymer nanoparticles have previously been able to transfect DNA into brain tissue after an intracerebral injection; these nanoparticles were similar in size and surface chemistry as LNPs, suggesting that LNPs will be able to transfect brain tissue after intracerebral injection (28, 30).”

    From Lipid Nanoparticles Deliver mRNA to the Brain after an Intracerebral Injection (2023) · cites this paper as [30]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 66 · Cited by 80

Research works printed but not linked: 67

  1. [1]O’Mahony AM Godinho BM Cryan JF O’Driscoll CM J Pharm Sci 2013 102 3469 23893329
  2. [2]Lentz TB Gray SJ Samulski RJ Neurobiol Dis 2012 48 179 22001604 PMC3293995
  3. [3]Perez-Martinez FC Carrion B Cena V J Alzheimers Dis 2012 31 697 22695620
  4. [4]Thomas CE Ehrhardt A Kay MA Nat Rev Genet 2003 4 346 12728277
  5. [5]Olsen NJ Stein CM N Engl J Med 2004 350 2167 15152062
  6. [6]Lowenstein PR Kroeger K Castro MG Neurotherapeutics 2007 4 715 17920552 PMC2268648
  7. [7]Sun X Zhang N Mini Rev Med Chem 2010 10 108 20408796
  8. [8]Kukowska-Latallo JF Raczka E Quintana A Chen C Rymaszewski M Baker JR Jr Hum Gene Ther 2000 11 1385 10910136
  9. [9]Sonawane ND Szoka FC Jr Verkman AS J Biol Chem 2003 278 44826 12944394
  10. [10]Tamaru M Akita H Kajimoto K Sato Y Hatakeyama H Harashima H Int J Pharm 2014 465 77 24530390
  11. [11]Langiu M Dadparvar M Kreuter J Ruonala MO PLoS One 2014 9 e107603 25229502 PMC4168126
  12. [12]Mishra S Webster P Davis ME Eur J Cell Biol 2004 83 97 15202568
  13. [13]Zhang Y Satterlee A Huang L Mol Ther 2012 20 1298 22525514 PMC3392980
  14. [14]DeLoid G Cohen JM Darrah T Derk R Rojanasakul L Pyrgiotakis G Wohlleben W Demokritou P Nat Commun 2014 5 3514 24675174 PMC4038248
  15. [15]Burke RS Pun SH Bioconjug Chem 2008 19 693 18293906
  16. [16]Jain KK Nanomedicine (Lond) 2012 7 1225 22931448
  17. [17]Patel T Zhou JB Piepmeier JM Saltzman WM Advanced Drug Delivery Reviews 2012 64 701 22210134 PMC3323692
  18. [18]Vykhodtseva N McDannold N Hynynen K Ultrasonics 2008 48 279 18511095 PMC2569868
  19. [19]Kroll RA Neuwelt EA Neurosurgery 1998 42 1083 99 discussion 1099 9588554
  20. [20]Nance EA Woodworth GF Sailor KA Shih TY Xu Q Swaminathan G Xiang D Eberhart C Hanes J Sci Transl Med 2012 4 149 PMC3718558 22932224
  21. [21]Sykova E Nicholson C Physiol Rev 2008 88 1277 18923183 PMC2785730
  22. [22]MacKay JA Deen DF Szoka FC Jr Brain Res 2005 1035 139 15722054
  23. [23]Voges J Reszka R Gossmann A Dittmar C Richter R Garlip G Kracht L Coenen HH Sturm V Wienhard K Heiss WD Jacobs AH Ann Neurol 2003 54 479 14520660
  24. [24]Zimmermann DR Dours-Zimmermann MT Histochem Cell Biol 2008 130 635 18696101
  25. [25]Kenny GD Bienemann AS Tagalakis AD Pugh JA Welser K Campbell F Tabor AB Hailes HC Gill SS Lythgoe MF McLeod CW White EA Hart SL Biomaterials 2013 34 9190 23948162
  26. [26]Allard E Passirani C Benoit JP Biomaterials 2009 30 2302 19168213
  27. [27]Writer MJ Kyrtatos PG Bienemann AS Pugh JA Lowe AS Villegas-Llerena C Kenny GD White EA Gill SS McLeod CW Lythgoe MF Hart SL J Control Release 2012 162 340 22800579 PMC3657147
  28. [28]Petersen H Fechner PM Martin AL Kunath K Stolnik S Roberts CJ Fischer D Davies MC Kissel T Bioconjug Chem 2002 13 845 12121141
  29. [29]Suk JS Kim AJ Trehan K Schneider CS Cebotaru L Woodward OM Boylan NJ Boyle MP Lai SK Guggino WB Hanes J J Control Release 2014 8 PMC3951606 24440664
  30. [30]Malek A Czubayko F Aigner A J Drug Target 2008 16 124 18274933
  31. [31]Merkel OM Urbanics R Bedocs P Rozsnyay Z Rosivall L Toth M Kissel T Szebeni J Biomaterials 2011 32 4936 21459440
  32. [32]Yang J Hendricks W Liu G McCaffery JM Kinzler KW Huso DL Vogelstein B Zhou S Proc Natl Acad Sci U S A 2013 110 14717 23959886 PMC3767543
  33. [33]Malek A Merkel O Fink L Czubayko F Kissel T Aigner A Toxicol Appl Pharmacol 2009 236 97 19371615
  34. [34]Lutz GJ Sirsi SR Williams JH Methods Mol Biol 2008 433 141 18679622
  35. [35]Yurek DM Flectcher AM Kowalczyk TH Padegimas L Cooper MJ Cell Transplant 2009 18 1183 19650971 PMC3031110
  36. [36]Yurek DM Fletcher AM Smith GM Seroogy KB Ziady AG Molter J Kowalczyk TH Padegimas L Cooper MJ Mol Ther 2009 17 641 19223866 PMC2835115
  37. [37]Konstan MW Davis PB Wagener JS Hilliard KA Stern RC Milgram LJ Kowalczyk TH Hyatt SL Fink TL Gedeon CR Oette SM Payne JM Muhammad O Ziady AG Moen RC Cooper MJ Hum Gene Ther 2004 15 1255 15684701
  38. [38]Pamujula S Hazari S Bolden G Graves RA Chinta DD Dash S Kishore V Mandal TK J Pharm Pharmacol 2012 64 61 22150673 PMC3319145
  39. [39]Hu Y Xie J Tong YW Wang CH J Control Release 2007 118 7 17241684
  40. [40]MacKay JA Li W Huang Z Dy EE Huynh G Tihan T Collins R Deen DF Szoka FC Molecular Therapy 2008 16 893 18388927
  41. [41]Stiles DK Zhang Z Ge P Nelson B Grondin R Ai Y Hardy P Nelson PT Guzaev AP Butt MT Charisse K Kosovrasti V Tchangov L Meys M Maier M Nechev L Manoharan M Kaemmerer WF Gwost D Stewart GR Gash DM Sah DW Exp Neurol 2012 233 463 22119622
  42. [42]Fox JH Connor T Stiles M Kama J Lu Z Dorsey K Liebermann G Sapp E Cherny RA Banks M Volitakis I DiFiglia M Berezovska O Bush AI Hersch SM Journal of Biological Chemistry 2011 286 18320 21454633 PMC3093904
  43. [43]Voges J Weber F Reszka R Sturm V Jacobs A Heiss WD Wiestler O Kapp JF Hum Gene Ther 2002 13 675 11916490
  44. [44]Zhou J Patel TR Sirianni RW Strohbehn G Zheng MQ Duong N Schafbauer T Huttner AJ Huang Y Carson RE Zhang Y Sullivan DJ Jr Piepmeier JM Saltzman WM Proc Natl Acad Sci U S A 2013 110 11751 23818631 PMC3718184
  45. [45]Salegio EA Streeter H Dube N Hadaczek P Samaranch L Kells AP San Sebastian W Zhai Y Bringas J Xu T Forsayeth J Bankiewicz KS Front Neuroanat 2014 8 9 24672434 PMC3956368
  46. [46]Guerrero-Cazares H Tzeng SY Young NP Abutaleb AO Quinones-Hinojosa A Green JJ ACS Nano 2014 8 5141 24766032 PMC4046784
  47. [47]Szerlip NJ Walbridge S Yang L Morrison PF Degen JW Jarrell ST Kouri J Kerr PB Kotin R Oldfield EH Lonser RR J Neurosurg 2007 107 560 17886556
  48. [48]Yin D Forsayeth J Bankiewicz KS J Neurosci Methods 2010 187 46 20026357 PMC2865230
  49. [49]Lieberman DM Laske DW Morrison PF Bankiewicz KS Oldfield EH J Neurosurg 1995 82 1021 7539062
  50. [50]Neeves KB Sawyer AJ Foley CP Saltzman WM Olbricht WL Brain Res 2007 1180 121 17920047 PMC2169304
  51. [51]Chen MY Lonser RR Morrison PF Governale LS Oldfield EH J Neurosurg 1999 90 315 9950503
  52. [52]Nguyen TT Pannu YS Sung C Dedrick RL Walbridge S Brechbiel MW Garmestani K Beitzel M Yordanov AT Oldfield EH J Neurosurg 2003 98 584 12650432
  53. [53]Casanova F Carney PR Sarntinoranont M PLoS One 2014 9 e94919 24776986 PMC4002424
  54. [54]Bernal GM LaRiviere MJ Mansour N Pytel P Cahill KE Voce DJ Kang S Spretz R Welp U Noriega SE Nunez L Larsen G Weichselbaum RR Yamini B Nanomedicine 2014 10 149 23891990 PMC3871979
  55. [55]Chen MY Hoffer A Morrison PF Hamilton JF Hughes J Schlageter KS Lee J Kelly BR Oldfield EH J Neurosurg 2005 103 311 16175862
  56. [56]Amoozgar Z Yeo Y Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012 4 219 22231928 PMC3288878
  57. [57]Ogris M Steinlein P Carotta S Brunner S Wagner E AAPS PharmSci 2001 3 E21 11741272 PMC2751016
  58. [58]Sonawane ND Szoka FC Jr Verkman AS Journal of Biological Chemistry 2003 278 44826 12944394
  59. [59]Davies LA McLachlan G Sumner-Jones SG Ferguson D Baker A Tennant P Gordon C Vrettou C Baker E Zhu J Alton EW Collie DD Porteous DJ Hyde SC Gill DR Mol Ther 2008 16 1283 18500249
  60. [60]Beyerle A Merkel O Stoeger T Kissel T Toxicol Appl Pharmacol 2010 242 146 54 19822165
  61. [61]Ziady AG Gedeon CR Muhammad O Stillwell V Oette SM Fink TL Quan W Kowalczyk TH Hyatt SL Payne J Peischl A Seng JE Moen RC Cooper MJ Davis PB Mol Ther 2003 8 948 14664797
  62. [62]Ziady AG Gedeon CR Miller T Quan W Payne JM Hyatt SL Fink TL Muhammad O Oette S Kowalczyk T Pasumarthy MK Moen RC Cooper MJ Davis PB Mol Ther 2003 8 936 14664796
  63. [63]Hosmane S Tegenge MA Rajbhandari L Uapinyoying P Kumar NG Thakor N Venkatesan A Journal of Neuroscience 2012 32 7745 22649252 PMC3398425
  64. [64]Schuster BS Suk JS Woodworth GF Hanes J Biomaterials 2013 34 3439 46 23384790 PMC3590854
  65. [65]Savin T Doyle PS Biophys J 2005 88 623 15533928 PMC1305040
  66. [66]Liu Y Liggitt HD Dow S Handumrongkul C Heath TD Debs RJ Journal of Biological Chemistry 2002 277 4966 11733533
  67. [67]Recinos VR Tyler BM Bekelis K Sunshine SB Vellimana A Li KW Brem H Neurosurgery 2010 66 530 20173548

Authors
Mastorakos, P., Zhang, C., Berry, S., Oh, Y., Lee, S., Eberhart, C. G., Woodworth, G. F., Suk, J. S., & Hanes, J.
Affiliations
  • Johns Hopkins University (US)
  • University of Maryland, Baltimore (US)
Corresponding author
  • Suk, Jung Soo
  • Hanes, Justin
Venue
Advanced Healthcare Materials
Publisher
Wiley
Published
2015-03-11
Volume
4
Issue
7
Pages
1023-1033
ISSN
  • 2192-2640 (ISSN-L)
  • 2192-2659
OpenAlex
W2121253175
Cited by
80
References
66
Citations by year
2026: 3 · 2025: 6 · 2024: 3 · 2023: 8 · 2022: 8 · 2021: 4 · 2020: 8 · 2019: 9 · 2018: 4 · 2017: 13 · 2016: 6 · 2015: 8
FWCI
4.48
Type
journal article
Language
en
Open access
Locations
  • Advanced Healthcare Materials (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (R01CA164789, T32CA130840, T32CA153952)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB020147)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
non-viral vectors, gene delivery to the brain, brain extracellular matrix, convection-enhanced delivery, nanoparticle dispersion, colloidally stable nanoparticles, transgene expression, central nervous system gene therapy, striatum, vector toxicity
MeSH terms
Animals, Brain, DNA, Extracellular Matrix, Genetic Vectors, Polyethylene Glycols, Polymers, Rabbits, Transfection, Genetic Therapy, Gene Transfer Techniques, Transgenes, Cell Line, Tumor, Rats, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review